Breast Cancer Clinical Trial
Rowing Following Breast Cancer Chemotherapy
Summary
There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise intervention on cardiovascular rehabilitation in breast cancer survivors.
Eligibility Criteria
Inclusion Criteria:
diagnosis of primary invasive non-metastatic breast cancer, stages I-III
female based on biological sex
40 to 80 years of age
completed chemotherapy 6 to 18 months prior to study enrollment
absence of contraindications to exercise or study participation
study clinician approval
Exclusion Criteria:
do not meet inclusion criteria
completed chemotherapy and/or other cancer treatment within past 6 months (e.g., surgery or radiation). Ovarian suppression within past 6 months is allowed.
receiving or scheduled to receive radiation therapy during study participation
scheduled to receive surgery during study participation
receiving or scheduled to receive other cancer treatment besides ovarian suppression during study participation
lymphedema stage ≥ 2 prior to study enrollment
any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)
body mass index ≥ 40 kg/m2
current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)
consistent participation in ≥150 min/week of moderate-intensity aerobic exercise training in previous 6 months
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Gainesville Florida, 32611, United States More Info
How clear is this clinincal trial information?